When does a declining HRV trend require a cardiologist visit rather than a protocol change?

Four situations that warrant a physician evaluation rather than a protocol adjustment: (1) sustained decline over eight or more weeks without identifiable cause (not explainable by a major life event, illness, overtraining, alcohol change, or travel); (2) declining HRV alongside new exertional symptoms, fatigue with stairs that was not present three months ago, reduced exercise tolerance, unexplained breathlessness during activity that previously felt easy; (3) declining HRV concurrent with resting heart rate rising by 10 or more beats per minute and sustained for more than three weeks; and (4) declining HRV in a man over 45 with any family history of premature cardiovascular events (first-degree relative with MI, stroke, or sudden cardiac death before age 60).

The clinical risk of not getting these evaluated is real: the wearable captures one cardiac signal while remaining blind to the coronary anatomy, the lipid-driven plaque, and the structural cardiac changes that could explain the decline. The ATRAMI findings establish that autonomic decline is a leading cardiac indicator, not a lagging one. The time to intervene is when the wearable is declining, not after the event the decline was forecasting. A cardiologist ordering a 12-lead ECG, stress test, and metabolic panel can often resolve the clinical question in a single visit. (La Rovere et al., Lancet, 199811144-8))

Cardiologist's calibrated position, Solid (1) for this triage framework.

What to do: Print or save the four criteria above. If you meet any one of them, book the appointment.

For the full picture, read Autonomic Sovereignty White Paper.